UNH Stock Confirms Uptrend As Investors Return And Outlook Improves
UnitedHealth Group is rebuilding momentum after a dramatic mid-year collapse, supported by renewed guidance, bullish analyst calls, and stab
Quick overview
- UnitedHealth Group is recovering from a significant stock decline, with shares climbing over 55% since August after reinstating guidance.
- Analysts are optimistic about the company's margin recovery, projecting earnings power of around $30 per share by 2028 or 2029.
- The company's outlook for Medicare Advantage enrollment is boosting confidence, with expectations of higher federal bonus payments.
- Berkshire Hathaway's $1.6 billion stake in UnitedHealth has further strengthened investor sentiment amid ongoing challenges.
UnitedHealth Group is rebuilding momentum after a dramatic mid-year collapse, supported by renewed guidance, bullish analyst calls, and stabilizing technical signals.
A Volatile Year Turns Toward Recovery
UnitedHealth Group (NYSE: UNH), the largest U.S. health insurer, has endured one of the sharpest reversals of sentiment in the healthcare space this year. After rallying near $600 in April, the stock plunged more than 60% to roughly $235 by early August. The collapse followed the company’s surprise decision to suspend forward-looking guidance—an announcement that rattled investors and fueled a wave of selling.
But the tide began to turn in late summer. When management reinstated its outlook during the second-quarter earnings release in July, market confidence began to rebuild. By October, shares had climbed more than 55% from their lows, reaching $380. While still far below the April peak, the recovery signaled that investors were once again willing to engage with the stock’s long-term story.
Renewed optimism intensified this week after Wolfe Research lifted its price target to $375 from $330, maintaining an Outperform rating. Several analysts now have targets stretching up to $440, reflecting expectations for a continued rebound into 2025.
Analysts See A Clear Path To Margin Recovery
Wolfe Research’s bullish outlook is primarily tied to expectations for stabilizing margins in UnitedHealthcare, the company’s core insurance segment. Restoring these margins is seen as the key driver for valuation expansion and sustained earnings growth.
The firm projects earnings power of around $30 per share by 2028 or 2029—an estimate that incorporates the company’s long-term plans for Optum Health, Medicare Advantage, and Medicaid. This outlook suggests meaningful upside if execution remains consistent.
Technical Landscape Shows Encouraging Progress
UnitedHealth’s technical picture has also strengthened after forming a multi-month bottom. In August, the stock bounced sharply off the long-term 200-month simple moving average (purple), a major structural support zone that halted the selloff.
UNH Chart Monthly – Buyers Need to Push Above the 100 SMA
The rebound carried shares back into the $380 region, where the 100-month SMA (green) capped further progress. A brief pullback followed, but buyers quickly stepped back in, producing two strong weekly gains and pushing the stock nearly 5% higher on Wednesday.
UNH Chart Weekly – The 20 SMA Is Acting As Support
If UNH can break and close decisively above the $380 level, the path appears open for a move toward $400–$420. Weekly charts further reinforce this view: the 20-week SMA (gray) acted as support after a doji reversal candle, followed by two firm bullish sessions.
Narrow Margins Remain A Core Challenge
Despite improving sentiment, structural challenges continue to shape the company’s near-term trajectory. U.S. health insurers operate with inherently slim margins due to regulatory constraints—including the mandate that at least 85% of premiums must be spent on medical claims.
Earlier in the year, UnitedHealth faced higher-than-expected utilization rates, meaning members accessed medical services more frequently than projected. This led the company to slash its 2025 earnings forecast from $24.65 to $14.65 per share—a cut that contributed heavily to the stock’s collapse.
While management is expected to address these pressures in the coming earnings release, investors remain cautious about the pace of margin normalization.
Medicare Advantage Outlook Supports The Turnaround
A major driver of the recent rebound is optimism around Medicare Advantage enrollment. UnitedHealth expects that 78% of its members will be in highly rated plans next year. Higher plan ratings translate into larger bonus payments from the federal government, generating billions in potential revenue.
This outlook has strengthened confidence in UnitedHealth’s long-term position in the senior healthcare market—a segment expected to expand significantly over the next decade as U.S. demographics shift.
Berkshire Hathaway’s Stake Strengthens Sentiment
Another major vote of confidence came from Berkshire Hathaway, which disclosed a $1.6 billion stake in the company as of June 30, representing more than five million shares. Although the investment dipped into the red during the stock’s second-quarter weakness, the recent rally has brought Berkshire close to breakeven.
The presence of Warren Buffett’s firm helped calm fears surrounding litigation risks and medical cost inflation, reinforcing the perception that UNH remains a high-quality long-term healthcare holding.
Mixed Results Leave Questions Ahead Of Q3
Second-quarter results offered both reassurance and uncertainty. While commercial membership and Optum Rx posted solid revenue gains, rising care costs pressured margins and weighed on overall earnings. Analysts currently expect 2025 revenue of $448.9 billion and EPS of $16.21, implying moderate recovery but not a return to early-2024 profitability levels.
Q3 results will be closely watched for signs of cost containment and operational efficiency—two key elements needed to sustain the stock’s ongoing rebound.
Dividend Stability Reinforces Investor Trust
UnitedHealth reaffirmed its $2.21 per-share dividend, a sign of financial stability despite recent volatility. In an environment marked by policy shifts and inflation uncertainty, reliable dividend income helps support investor confidence.
- Check out our free forex signals
- Follow the top economic events on FX Leaders economic calendar
- Trade better, discover more Forex Trading Strategies
- Open a FREE Trading Account
Save